NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies said today that it intends to raise up to A$4.5 million ($3.6 million) through the private placement of up to 324.7 million newly issued shares at a price of A$.014 each.
The company said that it has hired investment firm Lodge Corporate to assist with the proposed offering, which remains subject to shareholder approval.